Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

05 June 2015 : Review article  

Edoxaban: A Review of a Promising New Oral Factor Xa Inhibitor in Non-Valvular Atrial Fibrillation

Mohamed TelebE, Miraie WardiA, Maryna PoppB, Komola AzimovaB, Hasan J. SalamehD, Sarmad SaidF

DOI: 10.12659/MSRev.894613

Med Sci Rev 2015; 2:49-54

Abstract

Atrial fibrillation (AF), a common arrhythmia affecting many individuals around the globe, increases the risk of heart failure and thromboembolic events. With the increase in incidence and prevalence of AF, there is a large burden on the current health care system. Typical AF presents secondary to underlying heart disease or hypertension but can also be associated with atrial enlargement with increased pressure or with infiltrative or inflammatory processes in the atria. Warfarin has been the anticoagulant of choice for many years, but it requires close monitoring of the International Randomized Ratio (INR). Due to the common adverse effects of warfarin, new oral anticoagulants are under development to aid in decreasing the risk of bleeding without compromising stroke prevention. Edoxaban, a novel factor Xa inhibitor with promising anticoagulation effects with decreased bleeding, has recently been introduced. In this review, we will present the clinical trials that evaluated the efficacy of edoxaban, with emphasis on those which compared edoxaban to warfarin with regards to stroke prevention, major adverse reactions, and bleeding risk.

Keywords: Anticoagulants, Atrial Fibrillation, Factor Xa

Add Comment 0 Comments

Editorial

01 September 2023 : Editorial  

Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.942244

Med Sci Monit 2023; 29:e942244

0:00

In Press

28 Sep 2023 : Clinical Research  

Trends in Hospitalization Duration for Rare Diseases: A Retrospective Analysis of Sarcoidosis, Still's Dise...

Med Sci Monit In Press; DOI: 10.12659/MSM.941536  

27 Sep 2023 : Laboratory Research  

Enhanced Proliferation and Adhesion Marker Gene Expression in Fibroblast Cells: Evaluating the Efficacy of ...

Med Sci Monit In Press; DOI: 10.12659/MSM.941641  

26 Sep 2023 : Clinical Research  

Hypothalamic Injury and Clinical Outcomes in Patients with Post-Traumatic Hyponatremia: A Diffusion Tensor ...

Med Sci Monit In Press; DOI: 10.12659/MSM.942397  

26 Sep 2023 : Clinical Research  

Psychometric Properties of the Polish Version of the FACIT-Sp-12: Assessing Spiritual Well-Being Among Pati...

Med Sci Monit In Press; DOI: 10.12659/MSM.941769  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750